中东和非洲败血症诊断市场 – 行业趋势和 2029 年预测

市场分析和见解 ：中东和非洲败血症诊断市场

败血症诊断市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2022 年至 2029 年的预测期内，该市场将以 5.7% 的复合年增长率增长，预计将从 2021 年的 2061 万美元增至 2029 年的 3440 万美元。医院内感染发病率的上升和败血症患病率的上升推动了预测期内市场的需求。

败血症的历史可以追溯到 2700 多年前，当时它首次在古希腊荷马的诗歌中被提及（医学上）。在他的诗中，他使用了败血症这个词，该词源于希腊语“sepo”，意思是“我腐烂了”。败血症一词也出现在希波克拉底的著作中。他认为败血症是一种可能发生在体内的危险生物腐烂。罗马人进一步发展了败血症理论。败血症最著名的理论之一来自罗马医生盖伦，他的伤口愈合技术持续了 1500 年。他认为败血症是由一种看不见的生物产生的，这些生物会释放出一种叫做“瘴气”的烟雾。

19 世纪，维也纳医生 Ignaz Semmelweiss 对败血症做出了重大发现。他在产房工作时发现，产褥热（又称产褥脓毒症）导致的死亡率很高。后来，他发现一些同事死于手术感染，也就是尸检。Semmelweiss 得出结论，产褥脓毒症与进行尸检的医生之间存在联系。20 世纪 60 年代，美国医生 Edward Frank 制定了第一种脓毒症休克管理策略。1991 年，第一次脓毒症会议召开，旨在解决对脓毒症定义缺乏共识的问题，这种共识给脓毒症的诊断和治疗带来了困难。10 年后，即 2001 年，北美和欧洲的几个协会召开了第二次脓毒症会议，进一步明确了严重脓毒症和脓毒症休克的诊断标准，并制定了管理指南。

The increasing healthcare expenditure is expected to act as driver for the growth of the market. The lack of awareness about sepsis and its symptoms is expected to act as challenge for the growth of the market. The rising technological advancement leading to development of rapid diagnostics tests for early diagnosis of sepsis is expected to act as opportunity for the growth of the market. However, the shortage of healthcare professionals expected to challenge the market growth.

Sepsis Diagnostics Market Dyna

mics

Drivers

• Rise in incidence of hospital-acquired infections

The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. The rise in the incidences of hospital-acquired infections (HAIs) will increase the risk of sepsis and hence act as a major driver that will result in the expansion of the growth rate of the treatment market.

• Rise in healthcare expenditure

Another significant factor influencing the growth rate of sepsis diagnostics market is the rising healthcare expenditure which helps in improving its infrastructure.

• Grow in prevalence of sepsis

The rise in the prevalence of sepsis will further enhance the growth and hence act as a major driver for sepsis diagnostics market.

Furthermore, rise in technological advancements of sepsis diagnostic devices will expand the sepsis diagnostics market.

Opportunities

• Development of rapid diagnostic/point of care (POC) techniques for early sepsis diagnosis

Increasing need for the rapid diagnosis of sepsis to reduce the delay of antibiotic therapy among patients with sepsis will boost new opportunities for the market's growth rate.

Also, evolution of novel biomarkers for sepsis diagnosis will provide beneficial opportunities for the sepsis diagnostics market in the forecast period of 2022-2029.

Restraints/Challenges

However, lack of awareness about sepsis and shortage of skilled healthcare professionals will slow down the growth of sepsis diagnostics market. Additionally, high cost of diagnosis and lack of appropriate testing for sepsis will also prove to be harmful for a healthy growth of sepsis diagnostics market in the forecast period mentioned above.

This sepsis diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sepsis diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Sepsis Diagnostics Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine diagnosis/blood check-up, consultancy and medication administration will further affect the market. Social isolation increases dismissal of signs and symptoms of sepsis due to fear associated with visiting crowded hospitals and spread of misinformation during the pandemic.

Recent Development

• In January 2007, Cepheid and bioMerieux announced that they had entered into a strategic relationship wherein both companies will use the best of its respective technologies and commercial strengths towards the development and commercialization of an innovative line of sepsis test products on the GeneXpert platform.

Middle East and Africa Sepsis Diagnostics Market Scope

The sepsis diagnostics market is segmented into techniques and test type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Techniques

• Microbiology
• Molecular Diagnostic
• Immunoassay
• Flow Cytometry

On the basis of techniques, the Middle East and Africa sepsis diagnostics market is segmented into microbiology, molecular diagnostic, immunoassay, and flow cytometry.

Test Type

• Laboratory Testing
• Point of Care Testing

On the basis of test type, the Middle East and Africa sepsis diagnostics market is segmented into laboratory testing and point of care testing.

Sepsis Diagnostics Market Regional Analysis/Insights           

The sepsis diagnostics market is analysed and market size insights and trends are provided by country, techniques and test type as referenced above.

The countries covered in the sepsis diagnostics market report are Saudi Arabia, South Africa, rest of Middle East and Africa.

Saudi Arabia is expected to dominate the Middle East and Africa sepsis diagnostics market due to rising awareness among the public because of the wide initiation of sepsis awareness campaigns in the country. Middle East and Africa sepsis diagnostics market is expected to grow due to the rising number of research facilities and diagnostic clinics with better technological evolution in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Middle East and Africa brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Sepsis Diagnostics Market Share Analysis

The sepsis diagnostics market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on sepsis diagnostics market.

Some of the major players operating in the sepsis diagnostics market are Trinity Biotech (Ireland), Meridian Bioscience, Omega Diagnostics Group PLC., Xcyton Diagnostics Limited, Diasorin S.p.A, Seegene Inc., EKF Diagnostics Holdings plc., Axis-Shield Diagnostics Ltd., Immunexpress Inc., Luminex Corporation, bioMérieux SA, BD, Thermo Fisher Scientific Inc., Abbott, Roche Diagnostics, Cepheid, Beckman Coulter, Inc., T2 Biosystems, Inc., and Bruker Ortho Clinical Diagnostics among others.

Research Methodology: Middle East and Africa Sepsis Diagnostics Market

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、中东和非洲与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-67934